NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
NAVCO Pharmaceuticals Inc., a company specializing in nanotechnology for health products, has granted 3.9 million stock options to its officers, directors, and consultants at $0.05 per share, exercisable over ten years. These options, part of the company’s 2018 stock option plan, vest immediately to aid in the growth of NAVCO, which is focused on innovative defenses against pathogens in various markets, including human health and veterinary services.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.